Analysis of second-harmonic-generation microscopy in a mouse model of ovarian carcinoma

Journal of Biomedical Optics

Volumn 17, Issue 7, 2012, Pages

  Watson, Jennifer M ^a   Rice, Photini F ^a   Marion, Samuel L ^b   Brewer, Molly A ^c   Davis, John R ^b   Rodriguez, Jeffrey J ^d   Utzinger, Urs ^a   Hoyer, Patricia B ^b   Bartona, Jennifer K ^a  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

712 dimethylbenz a anthracene; Collagen; Imaging; Multiphoton; Ovarian cancer; Two photon

Indexed keywords

ALGORITHM; ANIMAL; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; FEMALE; IMAGE ENHANCEMENT; METHODOLOGY; MOUSE; MULTIPHOTON MICROSCOPY; OVARY TUMOR; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; ANIMALS; FEMALE; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICE; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84872040635     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.7.076002     Document Type: Article

References (55)

1. Cancer Facts and Figures 2011, American Cancer Society www.cancer.org (2011).
2. R. C. Bast, Jr. et al., "New tumor markers: Ca125 and beyond," Int. J. Gynecol. Cancer 15(Suppl 3), 274-281 (2005). (Pubitemid 43096594)
3. U. Menon et al., "Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)," Lancet Oncol. 10(4), 327-340 (2009).
4. A. P. Singh et al., "Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer," Lancet Oncol. 9(11), 1076-1085 (2008).
5. M. Donach et al., "Combined use of biomarkers for detection of ovarian cancer in high-risk women," Tumour Biol. 31(3), 209-215 (2010).
6. C. H. Clarke et al., "Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer," Gynecol. Oncol. 122(3), 548-553 (2011).
7. C. S. Zhu et al., "A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer," Cancer Prev. Res. (Phila.) 4(3), 375-383 (2011).
8. S. Milman, K. D. Whitney, and N. Fleischer, "Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125," Thyroid 21(8), 913-916 (2011).
9. R. Molina et al., "Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors," Tumour Biol. 24(4), 209-218 (2003). (Pubitemid 37500571)
10. C. C. Johnson et al., "The epidemiology of CA-125 in women without evidence of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial," Gynecol. Oncol. 110(3), 383-389 (2008).
11. A. S. Dehaghani et al., "Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women," Pathol. Oncol. Res.13(4), 360-364 (2007). (Pubitemid 351287319)
12. D. K. Pauler et al., "Factors influencing serum CA125II levels in healthy postmenopausal women," Cancer Epidemiol. Biomarkers Prev. 10(5), 489-493 (2001). (Pubitemid 32701635)
13. J. Tcherkassovaetal., "Combination of CA125 and RECAFbiomarkers for early detection of ovarian cancer," Tumour Biol. 32(4), 831-838 (2011).
14. L. S. Cohen et al., "Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction," Gynecol. Oncol. 82(1), 40-48 (2001). (Pubitemid 32634952)
15. D. A. Fishman et al., "The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer," Am. J. Obstet. Gynecol. 192(4), 1214-1222 (2005). (Pubitemid 40487801)
16. J. R. van Nagell, Jr. et al., "Ovarian cancer screening with annual transvaginal sonography: findings of 25, 000 women screened," Cancer 109(9), 1887-1896 (2007). (Pubitemid 46668555)
17. I. Ohel et al., "Three-dimensional power Doppler ultrasound in ovarian cancer and its correlation with histology," Arch. Gynecol. Obstet. 281(5), 919-925 (2010).
18. S. S. Buys et al., "Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial," JAMA 305(22), 2295-2303 (2011).
19. L. J. Havrilesky et al., "Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction," Cancer 117(3), 545-553 (2011).
20. M. Salhab, S. Bismohun, and K. Mokbel, "Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery," BMC Womens Health 10(28) (2010).
21. L. I. Batista et al., "Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome," BMC Cancer 8, 101 (2008).
22. W. A. Rocca et al., "Premature menopause or early menopause and risk of ischemic stroke," Menopause: J. N. Am. Menopause Soc. 19(3), 272-277 (2011).
23. J. Fanning, E. Yacoub, and R. Hojat, "Laparoscopic-assisted cytoreduc-tion for primary advanced ovarian cancer: Success, morbidity and survival," Gynecol. Oncol. 123(1), 47-49 (2011).
24. L. T. Shuster et al., "Prophylactic oophorectomy in premenopausal women and long-term health," Menopause Int. 14(3), 111-116 (2008).
25. U. Utzinger et al., "Reflectance spectroscopy for in vivo characterization of ovarian tissue," Lasers Surg. Med. 28(1), 56-66 (2001). (Pubitemid 32052603)
26. V. Untereiner et al., "Optical diagnosis of peritoneal metastases by infrared microscopic imaging," Anal. Bioanal. Chem. 393(6-7), 1619-1627 (2009).
27. L. P. Hariri et al., "Simultaneous optical coherence tomography and laser induced fluorescence imaging in rat model of ovarian carcinogenesis," Cancer Biol. Ther. 10(5), 438-447 (2010).
28. E. M. Kanter et al., "Dual modality imaging of a novel rat model of ovarian carcinogenesis," J. Biomed. Opt. 11(4), 041123 (2006).
29. M. A. Brewer et al., "Imaging of the ovary," Technol. Cancer Res. Treat. 3(6), 617-627 (2004). (Pubitemid 40023552)
30. L. P. Hariri et al., "Laparoscopic optical coherence tomography imaging of human ovarian cancer," Gynecol. Oncol. 114(2), 188-194 (2009).
31. Y. Yang et al., "Integrated optical coherence tomography, ultrasound and photoacoustic imaging for ovarian tissue characterization," Biomed. Opt. Express 2(9), 2551-2561 (2011).
32. Y Yang et al., "Optical scattering coefficient estimated by optical coherence tomography correlates with collagen content in ovarian tissue," J. Biomed. Opt. 16(9), 090504 (2011).
33. Y Yang et al., "Potential role of a hybrid intraoperative probe based on OCT and positron detection for ovarian cancer detection and characterization," Biomed. Opt. Express 2(7), 1918-1930 (2011).
34. S. F Elahi et al., "Longitudinal molecular imaging with single cell resolution of disseminated ovarian cancer in mice with a LED-based con-focal microendoscope," Mol. Imag. Biol. 13(6), 1157-1162 (2011).
35. A. A. Tanbakuchi et al., "Clinical confocal microlaparoscope for real-time in vivo optical biopsies," J. Biomed. Opt. 14(4), 044030 (2009).
36. A. Aguirre et al., "Coregistered three-dimensional ultrasound and photoacoustic imaging system for ovarian tissue characterization," J. Biomed. Opt. 14(5), 054014 (2009).
37. A. Aguirre et al., "Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization," Transl. Oncol. 4(1), 29-37 (2011).
38. N. J. Durr et al., "Maximum imaging depth of two-photon autofluorescence microscopy in epithelial tissues," J. Biomed. Opt. 16(2), 026008 (2011).
39. N. D. Kirkpatrick, M. A. Brewer, and U. Utzinger, "Endogenous optical biomarkers of ovarian cancer evaluated with multiphoton microscopy," Cancer Epidemiol. Biomarkers Prev. 16(10), 2048-2057 (2007). (Pubitemid 47621179)
40. R. M. Williams et al., "Strategies for highresolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy," Transl. Oncol. 3(3), 181-194 (2010).
41. O. Nadiarnykh et al., "Alterations of the extracellular matrix in ovarian cancer studied by second harmonic generation imaging microscopy," BMC Cancer 10(94), 1-14 (2010).
42. J. Adur et al., "Recognition of serous ovarian tumors in human samples by multimodal nonlinear optical microscopy," J. Biomed. Opt. 16(9), 096017 (2011).
43. D. Granot et al., "In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors," Cancer Res. 67(19), 9180-9189 (2007). (Pubitemid 47535904)
44. M. R. McLemore et al., "Epidemiologic and genetic factors associated with ovarian cancer," Cancer Nurs. 32(4), 281-290 (2009).
45. L. N. Springer et al., "Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats," Toxicol. Appl. Pharmacol. 139(2), 394-401 (1996). (Pubitemid 26281617)
46. L. P. Mayer et al., "The follicle-depleted mouse ovary produces androgen," Biol. Reprod. 71(1), 130-138 (2004). (Pubitemid 38915317)
47. Z. R. Craig et al., "7, 12-Dimethylbenz[a]anthracene induces Sertoli-Leydig cell tumors in the follicle-depleted ovaries of mice treated with 4-vinylcyclohexene diepoxide," Comp. Med. 60(1), 10-17 (2010).
48. Matlab R2011b Documentation. http://www.mathworks.com (2011).
49. R. M. Haralick, K. Shanmugam, and I. Dinstein, "Textural features for image classification," IEEE Trans. Syst. Man Cybern. SMC 3(6), 610-621 (1973).
50. C. Cortes and V. Vapnik, "Support-vector networks," Mach. Learn. 20(3), 273-297 (1995).
51. N. A. Obuchowski, "Receiver operating characteristic curves and their use in radiology," Radiology 229(1), 3-8 (2003). (Pubitemid 37152094)
52. M. H. Zweig and G. Campbell, "Receiver-operating characteristic plots: a fundamental evaluation tool in clinical medicine," Clin. Chem 39(4), 561-577 (1993). (Pubitemid 23118304)
53. A. W. Whitney, "A direct method of nonparametric measurement selection," IEEE Trans. Comput. 20(9), 1100-1103 (1971).
54. H. K. Roy et al., "Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk," Gastroenterology 135(4), 1069-1078 (2008).
55. M. C. King, J. H. Marks, and J. B. Mandell, and New York Breast Cancer Study Group, "Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2," Science 302(5645), 643-646 (2003). (Pubitemid 37310920)